Your browser doesn't support javascript.
loading
Fc-null anti-PD-1 monoclonal antibodies deliver optimal checkpoint blockade in diverse immune environments.
Moreno-Vicente, Julia; Willoughby, Jane E; Taylor, Martin C; Booth, Steven G; English, Vikki L; Williams, Emily L; Penfold, Christine A; Mockridge, C Ian; Inzhelevskaya, Tatyana; Kim, Jinny; Chan, H T Claude; Cragg, Mark S; Gray, Juliet C; Beers, Stephen A.
Afiliação
  • Moreno-Vicente J; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • Willoughby JE; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Taylor MC; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • Booth SG; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • English VL; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • Williams EL; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • Penfold CA; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • Mockridge CI; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • Inzhelevskaya T; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • Kim J; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • Chan HTC; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • Cragg MS; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • Gray JC; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
  • Beers SA; Antibody and Vaccine Group, Centre for Cancer Immunology, Cancer Sciences, University of Southampton, Southampton, UK.
J Immunother Cancer ; 10(1)2022 01.
Article em En | MEDLINE | ID: mdl-35017153
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico / Imunoterapia / Anticorpos Monoclonais / Neoplasias Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico / Imunoterapia / Anticorpos Monoclonais / Neoplasias Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido